首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Covered stents for true subclavian aneurysms in patients with degenerative connective tissue disorders.
【24h】

Covered stents for true subclavian aneurysms in patients with degenerative connective tissue disorders.

机译:退行性结缔组织疾病患者的真正锁骨下动脉瘤的覆膜支架。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To report the endovascular repair of rare true aneurysms of the subclavian artery in patients with degenerative connective tissue disorders. CASE REPORTS: Two patients, one with Marfan syndrome and the other with idiopathic cystic medial necrosis, presented with 3 subclavian artery aneurysms. A Wallgraft and 2 Viabahn covered stents were used to successfully exclude these aneurysms. After 3 months, the Wallgraft thrombosed, but the contralateral Viabahn remained patent at the most recent examination 13 months after treatment. The other patient with the unilateral aneurysm had a patent Viabahn stent-graft at 10 months. CONCLUSIONS: Patients with degenerative connective tissue disorders may benefit from less invasive treatment with stent-grafts. The more flexible Viabahn stent-graft may be better able to adapt to arterial tortuosity. However, the long-term results of this new technique have not yet been established.
机译:目的:报告退行性结缔组织疾病患者锁骨下动脉少见的真性动脉瘤的血管内修复。病例报告:两名患者,其中一名患有马凡氏综合征,另一名患有特发性囊性内侧坏死,表现为3例锁骨下动脉瘤。使用Wallgraft和2个Viabahn覆盖的支架成功排除了这些动脉瘤。 3个月后,Wallgraft血栓形成,但对侧Viabahn在治疗13个月后的最新检查中仍获得专利。另一名患有单侧动脉瘤的患者在10个月时接受了Viabahn专利支架移植术。结论:退行性结缔组织疾病患者可从支架植入物的微创治疗中受益。更加灵活的Viabahn支架植入物可能更好地适应动脉曲折。但是,这种新技术的长期结果尚未确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号